Dec 16 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO :
* ACERUS ANNOUNCES AMENDMENT TO CREDIT AGREEMENT, WAIVER OF CERTAIN Q4 FINANCIAL COVENANTS AND UPCOMING ADDITIONAL FINANCING FROM FIRST GENERATION CAPITAL
* ACERUS PHARMACEUTICALS - ONLY CHANGE CONTEMPLATED BY AMENDMENT IS TO SET LEVEL AT $2.0 MILLION UP FROM US$1.0 MILLION AT ALL TIMES AFTER JAN 31, 2020